郝艳忠，1999年出生，博士在读

教育经历：

2025/09-                   北京理工大学，材料学院，博士，导师：郭东升 教授
2022/09 - 2025/06，沈阳药科大学，无涯创新学院，硕士，导师：何仲贵 教授

2018/09 - 2022/06，沈阳药科大学，药学院，学士

研究兴趣：

已发表工作：
1. The delicate disulfide-acryloyl modification of prodrug facilitates precise albumin targeting, enhanced tumor accumulation and reduced toxicity, Yanzhong Hao, Yaqiao Li, Lu Li, Wenfeng Zang, Zhenzhen Zhao, Zhonggui He, Bingjun Sun, Journal of Medicinal Chemistry.
2. Self-assembled doxorubicin prodrug riding on the albumin express train enable tumor targeting and bio-activation, Yanzhong Hao, Yaqiao Li, Wenfeng Zang, Yixin Sun, Xin Li, Lin Li, Zhonggui He, Bingjun Sun, Journal of Colloid and Interface Science.